Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A.
Zonta F, Pagano MA, Trentin L, Tibaldi E, Frezzato F, Trimarco V, Facco M, Zagotto G, Pavan V, Ribaudo G, Bordin L, Semenzato G, Brunati AM.
Zonta F, et al. Among authors: bordin l.
Blood. 2015 Jun 11;125(24):3747-55. doi: 10.1182/blood-2014-12-619155. Epub 2015 Apr 30.
Blood. 2015.
PMID: 25931585
Free article.